查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604692

人造器官和仿生市場：按產品和技術分類的全球預測 - 2025-2030

Artificial Organ & Bionics Market by Product (Artificial Bionics, Artificial Organ), Technology (Electronic, Mechanical) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，人造器官和仿生市場價值為233.4億美元，預計到2024年將達到254.5億美元，複合年成長率為9.10%，到2030年將達到429.7億美元。

人造器官和仿生市場涉及生物相容性設備的開發，這些設備可增強或取代故障的器官和組織的功能。它是生物技術和生物工程的結合所定義的，包括人工腎臟、人工心臟、人工肺部和人工耳等。由於器官衰竭、慢性疾病增加和捐贈器官短缺，這一階段是必要的。應用涵蓋許多醫療領域，特別是在心臟和糖尿病管理（矯正器具仿生胰腺）、運動性能增強（義肢）和感覺恢復（人工電子耳）方面。最終用戶主要包括醫院、研究機構以及需要復健和改善生活品質的患者。

主要市場統計
基準年[2023] 233.4億美元
預計年份 [2024] 254.5億美元
預測年份 [2030] 429.7億美元
複合年成長率（%） 9.10%

市場成長的關鍵驅動力是 3D 列印和幹細胞技術等技術進步，這些技術正在徹底改變設備製造和個人化醫療。有利的監管措施和不斷成長的醫療保健支出將進一步推動市場擴張。在人口老化和器官衰竭盛行率不斷增加的市場中，機會無所不在。新興地區、技術先進的產品供應以及創新解決方案聯盟是潛在的成長要素。公司應透過投資研發、形成策略聯盟並強調個人化醫療以滲透市場來抓住這些機會。

然而，市場面臨著高昂的開發和實施成本、嚴格的監管合規性以及有關長期整合和功能的道德問題等限制。此外，技術的複雜性和所需的多學科專業知識為快速市場引入帶來了挑戰。

創新應著重於提高設備的生物相容性和使用壽命、降低製造成本，並利用人工智慧在患者特定解決方案中進行預測分析。探索侵入性較小的安裝方法並整合物聯網進行監控也可能會增加競爭。市場充滿活力且快速成長，但迫切需要平衡成本、可近性和創新性。成功需要一種策略方法，重點是克服現有的限制，同時利用新的機會。

市場動態：快速發展的人造器官和仿生市場的關鍵市場洞察

人造器官和仿生市場正因供需的動態互動而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 慢性疾病導致的器官衰竭增加
    • 導致截肢的案例增加
    • 實現醫療基礎設施現代化並增加醫療支出
  • 市場限制因素
    • 人工移植手術的高成本
  • 市場機會
    • 人工器官移植技術的進展
    • 開發新的和改進的人造器官
  • 市場問題
    • 是否有嚴格的法律規範？

波特的五力：駕馭人造器官與仿生市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解外部對人造器官和仿生市場的影響

外部宏觀環境因素在塑造人造器官和仿生市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解人造器官和仿生市場的競爭狀況

人工器官和仿生學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣：人造器官與仿生市場供應商績效評估

FPNV 定位矩陣是評估人工器官和仿生市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：在人造器官和仿生市場上開闢成功之路

人造器官和仿生市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病導致器官衰竭的發生率增加
      • 導致截肢的交通事故增加
      • 醫療基礎設施現代化和醫療費用上漲
    • 抑制因素
      • 人工移植手術的高成本
    • 機會
      • 人工器官移植手術的進展
      • 開發新的和改進的人造器官
    • 任務
      • 嚴格的法規結構的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章人造器官與仿生市場：依產品

  • 介紹
  • 人工仿生學
    • 仿生肢體
    • 腦仿生學
    • 人工電子耳
    • 外骨骼
    • 視覺仿生學
  • 人造器官
    • 心
    • 腎
    • 肝
    • 肺
    • 胰臟

第7章人造器官與仿生市場：依技術分類

  • 介紹
  • 電子的
  • 機器

第8章 北美、南美人工器官及仿生市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太人工器官及仿生市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的人造器官和仿生市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Alt-Bionics, LLC
  • Axiles Bionics
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Beta Bionics, Inc.
  • Bionic India
  • Boston Scientific Corporation
  • Carmat SA
  • COVVI Ltd.
  • Ekso Bionics Holdings, Inc.
  • German Bionic Systems GmbH
  • iWALKFree, Inc.
  • Jarvik Heart, Inc.
  • Medtronic Plc
  • Nipro Corporation
  • Open Bionics Ltd.
  • Pixium Vision SA
  • ReWalk Robotics Ltd.
  • Sonova AG
  • SynCardia Systems, LLC
  • Vivani Medical, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf.
Product Code: MRR-A339DAEFA09B

The Artificial Organ & Bionics Market was valued at USD 23.34 billion in 2023, expected to reach USD 25.45 billion in 2024, and is projected to grow at a CAGR of 9.10%, to USD 42.97 billion by 2030.

The artificial organ and bionics market involves the development of biocompatible devices that enhance or substitute the function of impaired organs or tissues. Defined by its integration of biotechnology and bioengineering, the scope encompasses artificial kidneys, hearts, lungs, ears, and more. This field is necessitated by the rising prevalence of organ failures, chronic diseases, and the shortage of donor organs. Applications span numerous medical fields, prominently in cardiac and diabetes management (e.g., bionic pancreas), mobility enhancement (prosthetics), and sensory restoration (cochlear implants). End-users predominantly include hospitals, research institutions, and patients requiring rehabilitation or quality of life improvements.

KEY MARKET STATISTICS
Base Year [2023] USD 23.34 billion
Estimated Year [2024] USD 25.45 billion
Forecast Year [2030] USD 42.97 billion
CAGR (%) 9.10%

Market growth is primarily driven by technological advancements, such as 3D printing and stem cell technology, which are revolutionizing device manufacturing and personalized medicine. Favorable regulatory policies and increased healthcare expenditure further catalyze market expansion. Opportunities abound in markets with aging populations and increasing incidence of organ failure. Emerging regions, technologically advanced product offerings, and collaborations for innovative solutions are potential levers for growth. Businesses should pivot towards these opportunities by investing in R&D, forming strategic alliances, and emphasizing personalized medicine for market penetration.

However, the market faces constraints, including high costs of development and implementation, stringent regulatory compliance, and ethical concerns regarding long-term integration and functionality. Additionally, technological complexity and required multidisciplinary expertise pose challenges for swift market adoption.

To innovate, focus should be on enhancing biocompatibility and longevity of devices, reducing manufacturing costs, and leveraging AI for predictive analytics in patient-specific solutions. Exploring minimally invasive installation methods and integrating IoT for monitoring could also provide a competitive edge. The market is dynamic and burgeoning, yet intensely requires balancing cost, accessibility, and technological innovation. A strategic approach focusing on overcoming existing limitations while capitalizing on new opportunities will be critical for success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Organ & Bionics Market

The Artificial Organ & Bionics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of organ failure due to chronic diseases
    • Increasing cases of road accidents leading to amputations
    • Modernization of healthcare infrastructure and rise in healthcare spending
  • Market Restraints
    • High costs associated with artificial implantation procedures
  • Market Opportunities
    • Advancement in the implantation of artificial organ procedures
    • Development of new and improved artificial organs
  • Market Challenges
    • Availability of stringent regulatory frameworks

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Organ & Bionics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Organ & Bionics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Organ & Bionics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Organ & Bionics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Organ & Bionics Market

A detailed market share analysis in the Artificial Organ & Bionics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Organ & Bionics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Organ & Bionics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Organ & Bionics Market

A strategic analysis of the Artificial Organ & Bionics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Organ & Bionics Market, highlighting leading vendors and their innovative profiles. These include Alt-Bionics, LLC, Axiles Bionics, Baxter International Inc., Berlin Heart GmbH, Beta Bionics, Inc., Bionic India, Boston Scientific Corporation, Carmat SA, COVVI Ltd., Ekso Bionics Holdings, Inc., German Bionic Systems GmbH, iWALKFree, Inc., Jarvik Heart, Inc., Medtronic Plc, Nipro Corporation, Open Bionics Ltd., Pixium Vision SA, ReWalk Robotics Ltd., Sonova AG, SynCardia Systems, LLC, Vivani Medical, Inc., Zimmer Biomet Holdings, Inc., and Ossur hf..

Market Segmentation & Coverage

This research report categorizes the Artificial Organ & Bionics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Artificial Bionics and Artificial Organ. The Artificial Bionics is further studied across Bionic Limbs, Brain Bionics, Cochlear Implants, Exoskeleton, and Vision Bionics. The Artificial Organ is further studied across Heart, Kidney, Liver, Lungs, and Pancreas.
  • Based on Technology, market is studied across Electronic and Mechanical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of organ failure due to chronic diseases
      • 5.1.1.2. Increasing cases of road accidents leading to amputations
      • 5.1.1.3. Modernization of healthcare infrastructure and rise in healthcare spending
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with artificial implantation procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in the implantation of artificial organ procedures
      • 5.1.3.2. Development of new and improved artificial organs
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of stringent regulatory frameworks
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Organ & Bionics Market, by Product

  • 6.1. Introduction
  • 6.2. Artificial Bionics
    • 6.2.1. Bionic Limbs
    • 6.2.2. Brain Bionics
    • 6.2.3. Cochlear Implants
    • 6.2.4. Exoskeleton
    • 6.2.5. Vision Bionics
  • 6.3. Artificial Organ
    • 6.3.1. Heart
    • 6.3.2. Kidney
    • 6.3.3. Liver
    • 6.3.4. Lungs
    • 6.3.5. Pancreas

7. Artificial Organ & Bionics Market, by Technology

  • 7.1. Introduction
  • 7.2. Electronic
  • 7.3. Mechanical

8. Americas Artificial Organ & Bionics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Artificial Organ & Bionics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Artificial Organ & Bionics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alt-Bionics, LLC
  • 2. Axiles Bionics
  • 3. Baxter International Inc.
  • 4. Berlin Heart GmbH
  • 5. Beta Bionics, Inc.
  • 6. Bionic India
  • 7. Boston Scientific Corporation
  • 8. Carmat SA
  • 9. COVVI Ltd.
  • 10. Ekso Bionics Holdings, Inc.
  • 11. German Bionic Systems GmbH
  • 12. iWALKFree, Inc.
  • 13. Jarvik Heart, Inc.
  • 14. Medtronic Plc
  • 15. Nipro Corporation
  • 16. Open Bionics Ltd.
  • 17. Pixium Vision SA
  • 18. ReWalk Robotics Ltd.
  • 19. Sonova AG
  • 20. SynCardia Systems, LLC
  • 21. Vivani Medical, Inc.
  • 22. Zimmer Biomet Holdings, Inc.
  • 23. Ossur hf.

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL ORGAN & BIONICS MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ARTIFICIAL ORGAN & BIONICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ARTIFICIAL ORGAN & BIONICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL ORGAN & BIONICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL ORGAN & BIONICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIONIC LIMBS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BRAIN BIONICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY EXOSKELETON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY VISION BIONICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY LUNGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ELECTRONIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGAN, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. ARTIFICIAL ORGAN & BIONICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. ARTIFICIAL ORGAN & BIONICS MARKET, FPNV POSITIONING MATRIX, 2023